The establishment of EVISA is funded by the EU through
the Fifth Framework Programme (G7RT- CT- 2002- 05112).
Supporters of EVISA includes:
generation water-soluble gold(1) thiolate metallodrug used for
treatment of rheumatoid arthritis. Serious side effects led to the
development of second generation gold drugs such as auranofin.
IUPAC name : auriothiomalate